title: Benefits of hydroxyethyl starch: lost in translation?
authors.forename: Peter
authors.initials: P
authors.lastname: Gosling
mesh_terms: D003422:Critical Care / Q000379:methods; D016638:Critical Illness / Q000401:mortality / Q000628:therapy; D003911:Dextrans / Q000008:administration & dosage; D005260:Female; D005780:Gelatin / Q000008:administration & dosage; D006439:Hemodynamics / Q000502:physiology; D006801:Humans; D006895:Hydroxyethyl Starch Derivatives / Q000008:administration & dosage*; D020896:Hypovolemia / Q000175:diagnosis / Q000628:therapy; D007362:Intensive Care Units; D008297:Male; D010952:Plasma Substitutes / Q000008:administration & dosage* / Q000737:chemistry; D015427:Reperfusion Injury / Q000628:therapy*; D012680:Sensitivity and Specificity; D014655:Vascular Resistance / Q000187:drug effects
chemical_list: D003911:Dextrans; D006895:Hydroxyethyl Starch Derivatives; D010952:Plasma Substitutes; D005780:Gelatin